WORLD-FIRST EXPERIMENTAL CANCER TREATMENT PAVES WAY FOR CLINICAL TRIAL
Nature Medicine has published a peer reviewed paper detailing the experimental glioblastoma cancer treatment developed by Professor Georgina Long AO, Medical Director of Melanoma Institute Australia, paving the way for a clinical trial to be conducted by researchers at The Brain Cancer Centre in Melbourne.
Professor Long used her expertise in immunotherapy and drew on melanoma science to devise, lead and administer the treatment, the first documented use of neoadjuvant triple immunotherapy in glioblastoma.
LATEST NEWS
Recordings of MPA-MIA Melanoma Community Webinar Series 2025
Watch recordings of our MPA-MIA Melanoma Community Webinar series once they have been held. Recording of Webinar One - 'Genetic testing for melanoma' is now live.
NHMRC grants for UNCUT and Automate Me clinical trials
Prestigious National Health and Medical Research Council (NHMRC) grants have been awarded for two clinical trials aiming to improve the accuracy of skin cancer diagnosis in Australia.
MIA clinicians & researchers share latest results at ASCO25
Read more about MIA clinicians and researchers in Chicago for ASCO25 - the American Society of Clinical Oncology Annual Meeting - to share latest research and clinical trial results with international colleagues.
Creative and courageous community fundraisers
We recognise our incredible community of fundraisers who continue to amaze us with their courage and creativity. From comedy nights and golf days to marathons, music gigs, Facebook fundraisers and more – they've found unique ways to make a difference.
Public consultation on Melanoma Clinical Guidelines
The working party updating the 'Clinical Practice Guidelines for the Diagnosis and Management of Melanoma' is now seeking comment from clinicians and the community.
Minimising surgery and drug intervention
Three studies led by researchers at Melanoma Institute Australia (MIA) are paving the way for less surgical and drug intervention for early stage melanoma patients.
MIA’s MISSION
ZERO DEATHS FROM MELANOMA
MIA will achieve its mission through 3 pillars of action: Research, Clinical Care & Education.
MIA conducts its research under 4 themes: Prevention, Risk & Clinical Detection – Early Melanoma – Advanced Melanoma – Supportive Care & Survivorship.
1300
It is estimated 1300 Australians will die from melanoma this year
30 mins
1 Australian is diagnosed with melanoma every 30 minutes
90%
If caught early 90% of melanomas can be cured by surgery
Age 20-39
Melanoma is the most common cancer affecting Australians aged 20 to 39
